July 13, 2026
Monday, July 13, 2026
Today: 8 trending tweets, 6 new studies.
New Research
Pharmacologic Treatment for Obstructive Sleep Apnea in Older Adults.
Drugs & aging
Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Auditable large language model curation of clinical notes refines glucagon-like peptide-1 initiation, persistence ascertainment, and compounding use beyond prescription records.
Biology methods & protocols
TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications.
Handbook of experimental pharmacology
Tirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort study.
BMC cardiovascular disorders
Lead-guided prodrug development of small molecules as GLP-1R agonists.
Bioorganic chemistry
Trending on X
The ultimate peptide cheatsheet. Here's every peptide worth knowing, sorted by what it does in your body: Fat loss: → AOD-9604 → 5-Amino-1MQ → Tesofensine → MOTS-c → Setmelanotide → LIPO-C: GLP-1 receptor agonists: → Semaglutide → Tirzepatide → Retatrutide →
Who the July 23–24 peptide panel is made up of might be the biggest tell we have that the peptide bull market is just getting started. Reuters reported that 7 of the 14 panelists have ties to peptide clinics or peptide therapy businesses. If that’s not a sign that a handful of
We just crossed 2,000 Reptides subscribers, and we're climbing fast. Reptides Briefs is core to what we're building. It's our editorial platform: a free monthly newsletter, plus a paid layer of deeper dives for premium members. We publish full dossiers on single peptides like
We just crossed 2,000 Reptides subscribers, and we're climbing fast. Reptides Briefs is core to what we're building. It's our editorial platform: a free monthly newsletter, plus a paid layer of deeper dives for premium members. We publish full dossiers on single peptides like
Three compounds in the typical peptide conversation are actually FDA-approved drugs semaglutide, tirzepatide, tesamorelin. The rest are not approved. The menu won't tell you which is which.
Here’s a quick breakdown of the key differences between general peptides and Khavinson-style bioregulators: Peptides are short chains of amino acids (typically 2–50). They include hormones (insulin), growth factors (BPC-157, TB-500), signaling molecules (semaglutide), and many
GLP/peptide talk translation: • “Gray market = sold outside authorized prescription/pharmacy channels. • “Research” = labeled “for research—not approved for human use” to enable sale in the US. • GLP-1 = the hormone pathway targeted by this drug class (Sema) • GLP-2 = https://t.co/jw0vVEq3xI
Standing offer to every peptide price tracker: list us. If any vendor on your board beats our price on the same product, we'll match it and publish the comparison. Current pricing (sold as 10-vial kits): Retatrutide 10mg — $1.12/mg Tirzepatide 10mg — $0.69/mg Semaglutide 10mg
Provider Spotlight
TrimRx
Doctor-supervised telehealth weight loss platform offering compounded semaglutide and tirzepatide in injectable and oral formats. Operated by MetaFit Pharma Solutions LLC. Free shipping, plans from $149/mo with new patient offer.